- Report
- June 2025
- 287 Pages
Global
From €5252EUR$5,850USD£4,470GBP
Cyproterone Acetate is a synthetic steroidal antiandrogen used in the treatment of endocrine and metabolic disorders. It is used to treat conditions such as hirsutism, acne, androgen-dependent alopecia, and prostate cancer. It works by blocking the action of androgens, hormones that are responsible for male characteristics. It is also used to reduce the risk of developing prostate cancer in men with an increased risk of the disease.
Cyproterone Acetate is available in both oral and injectable forms. It is usually prescribed in combination with other drugs, such as estrogens, to reduce the risk of side effects. Common side effects include nausea, vomiting, headache, and weight gain.
The market for Cyproterone Acetate is driven by the increasing prevalence of endocrine and metabolic disorders, as well as the growing demand for effective treatments. The availability of generic versions of the drug has also contributed to its market growth.
Some of the major companies in the Cyproterone Acetate market include Pfizer, Merck, Novartis, Sanofi, and Bayer. Show Less Read more